FDA Approves Tarceva in Combination with Gemcitabine Chemotherapy for Treatment of Locally Advanced, Inoperable or Metastatic Pancreatic Cancer
3rd Nov 2005, 13:12 GMT
OSI Pharmaceuticals and Genentech announced that the US FDA approved Tarceva in combination with gemcitabine chemotherapy for the treatment of advanced pancreatic cancer in patients who have not received previous chemotherapy.
FDA Approves Tarceva in Combination with Gemcitabine Chemotherapy for Treatment of Locally Advanced, Inoperable or Metastatic Pancreatic Cancer related news:
- Multimedia News Release -- FDA Approves Tarceva(R) in Combination With Gemcitabine Chemotherapy for Treatment of Locally Advanced, Inoperable or Metastatic Pancreatic Cancer — PR Newswire: All Releases
- Tarceva gets FDA go-ahead for pancreatic cancer treatment — The Earth Times Online Newspaper
- Extra Drug May Help Pancreatic Cancer (Associated Press) —
- Extra Drug May Help Pancreatic Cancer — WTOP Radio - Health News
- ECCO: Xeloda-Gemzar Duo Extends Pancreatic Cancer Survival — MedPage Today.com Latest Headlines
- Tarceva Approved for Treatment of Pancreatic Cancer — MedPage Today OB/GYN
- Gemcitabine and capecitabine improved overall survival in patients with advanced pancreatic cancer — EurekAlert! - Breaking News
- FDA Approves 1st New Therapy in 9 Years for Treatment of Advanced Pancreatic Cancer — Government/ Industry Regulation News from StratCenter.com
- Drug adds time in cancer cases — HeraldNet
- New treatment for pancreatic cancer — the Mail online | Health news
Latest news from Partnerships/ Joint Ventures News from StratCenter.com:
- Local firm forms foundation for women's sexual health
- Lifeline Therapeutics to Recognize Previously Deferred Retail Chain Revenue
- Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting
- NextGen Healthcare and Primetime Medical Software Partner to Enhance Communications Between Doctors and Patients
- 3 Keane Executives to Present at the 2006 Gartner Healthcare Summit in San Diego
- Yaupon Therapeutics Closes $4 mln Financing
- CareTech Solutions and Yampa Valley Med Cntr Announce New IT Outsourcing Agreement
- Genelabs Technologies Reports Financial Results for Q3 and 1st 9 Months of 2006
- Frost & Sullivan Honors Covance for Superior Market Leadership, Creating Enhanced Customer Value in the North American CRO Market
- Health Care Property Closes $1B Offering